SCHEMBL21101909

SCHEMBL21101909

CC(=O)Cc1cccc(C(C)(C)F)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.50
CYP2C19 P33261 1/20 0.50
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
MAPT P10636 2/20 0.47
MAOB P27338 2/20 0.43
ACP3 P15309 1/20 0.42
PGK1 P00558 1/20 0.41
PGK2 P07205 1/20 0.41
EPHX1 P07099 1/20 0.41
GFER P55789 1/20 0.41
IDO1 P14902 2/20 0.41
HTT P42858 2/20 0.41
SMYD3 Q9H7B4 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
HDAC1 Q13547 2/20 0.40
HDAC8 Q9BY41 2/20 0.40
HDAC3 O15379 1/20 0.40
HDAC4 P56524 1/20 0.40
HDAC7 Q8WUI4 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL265041 0.88 MEN1 (0.59) MEN1KMT2AMAPTMAOBACP3
SCHEMBL30412285 0.88 MEN1 (0.59) MEN1KMT2AMAPTMAOBACP3
SCHEMBL13547858 0.86 CYP1A2 (0.53) CYP1A2CYP2C19MEN1KMT2AMAPT
Formaldehyde SCHEMBL9181082 0.85 MEN1 (0.56) MEN1KMT2AMAPTMAOBACP3
SCHEMBL20057999 0.83 CYP1A2 (0.43) CYP1A2CYP2C19MEN1KMT2AMAPT
SCHEMBL21101918 0.82 TACR1 (0.37) CYP1A2CYP2C19IDO1
SCHEMBL6509671 0.79 ALDH1A1 (0.46) CYP1A2CYP2C19ALDH1A1
SCHEMBL21101910 0.78 POLB (0.46) CYP2C19MAPTMAOBHDAC1HDAC8
SCHEMBL20811436 0.77 HTR2A (0.47) CYP1A2CYP2C19MAPTACP3PGK1
SCHEMBL21101912 0.77 TACR1 (0.35) CYP1A2CYP2C19IDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019111225-A1 COMPOUNDS AND METHODS FOR THE TREATMENT OF NON‑ALCOHOLIC STEATOHEPATITIS AVALIV THERAPEUTICS (US) 2019-06-13 WO disclosed